High PDLIM2 expression is associated with M2 macrophage infiltration, which is often considered a hallmark feature of invasive breast cancer, particularly triple-negative breast cancer (Cox et al., 2022). Here, PDLIM2 is linked to triple-negative breast carcinoma.